Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yola Moride

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Arthritis Research & Therapy|March 4, 2005
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control studyYola Moride, Thierry Ducruet, Jean-François Boivin, et al.
Pharmacoepidemiology and Drug Safety|March 12, 2014
Methodological gaps in the assessment of risk minimization interventions: a systematic reviewInna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Factors associated with persistence of cholinesterase inhibitor treatments in the elderlyAntoine Pariente, Marion Pinet, Yola Moride, et al.
Clinical Pharmacology and Therapeutics|September 11, 2019
Secondary Stroke Prevention: A Population-Based Cohort Study on Anticoagulation and Antiplatelet Treatments, and the Risk of Death or RecurrenceMareva Faure, Anne-Marie Castilloux, Agnès Lillo-Le-Louet, et al.
Drugs & Aging|October 31, 2012
Effect of external variables on the performance of the geriatric comorbidity score derived from prescription claims in the community-dwelling elderlySarah-Gabrielle Béland, Cara Tannenbaum, Thierry Ducruet, et al.
Journal of Blood Medicine|March 9, 2023
Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic ReviewPing Du, Aurore Bergamasco, Yola Moride, et al.
Clinical Therapeutics|July 16, 2002
Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectivenessChristina Wolfson, Mark Oremus, Vijay Shukla, et al.
Drug Safety|November 17, 2010
Case series in drug safety: a review to determine characteristics and qualityClaire Nour Abou Chakra, Antoine Pariente, Marion Pinet, et al.
Drug Safety|February 10, 2021
Risk Management for the 21st Century: Current Status and Future NeedsRania Mouchantaf, Doris Auth, Yola Moride, et al.
Age and Ageing|December 11, 2008
The risk of cognitive impairment in older community-dwelling women after benzodiazepine useRajaa Lagnaoui, Marie Tournier, Yola Moride, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Arthritis Research & Therapy|March 4, 2005
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control studyYola Moride, Thierry Ducruet, Jean-François Boivin, et al.
Pharmacoepidemiology and Drug Safety|March 12, 2014
Methodological gaps in the assessment of risk minimization interventions: a systematic reviewInna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, et al.
Pharmacoepidemiology and Drug Safety|June 29, 2010
Factors associated with persistence of cholinesterase inhibitor treatments in the elderlyAntoine Pariente, Marion Pinet, Yola Moride, et al.
Clinical Pharmacology and Therapeutics|September 11, 2019
Secondary Stroke Prevention: A Population-Based Cohort Study on Anticoagulation and Antiplatelet Treatments, and the Risk of Death or RecurrenceMareva Faure, Anne-Marie Castilloux, Agnès Lillo-Le-Louet, et al.
Drugs & Aging|October 31, 2012
Effect of external variables on the performance of the geriatric comorbidity score derived from prescription claims in the community-dwelling elderlySarah-Gabrielle Béland, Cara Tannenbaum, Thierry Ducruet, et al.
Journal of Blood Medicine|March 9, 2023
Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic ReviewPing Du, Aurore Bergamasco, Yola Moride, et al.
Clinical Therapeutics|July 16, 2002
Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectivenessChristina Wolfson, Mark Oremus, Vijay Shukla, et al.
Drug Safety|November 17, 2010
Case series in drug safety: a review to determine characteristics and qualityClaire Nour Abou Chakra, Antoine Pariente, Marion Pinet, et al.
Drug Safety|February 10, 2021
Risk Management for the 21st Century: Current Status and Future NeedsRania Mouchantaf, Doris Auth, Yola Moride, et al.
Age and Ageing|December 11, 2008
The risk of cognitive impairment in older community-dwelling women after benzodiazepine useRajaa Lagnaoui, Marie Tournier, Yola Moride, et al.
Pageof 9